Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period
This course on antidepressant treatment for depression during pregnancy and postpartum reviews the comparative benefits and harms of treatment for depression in woman who are pregnant or experiencing postpartum depression. It is based upon material published by the Agency for Healthcare Research and Quality (AHRQ) and is available as an open access article.
A wide array of nonpharmacological interventions can be used to treat depression, including various psychotherapies, electroconvulsive therapy, repetitive transcranial magnetic stimulation, and acupuncture.15-19 Some of these may be used during pregnancy, whereas others may be reserved for use in the postpartum period (e.g., electroconvulsive therapy). Decisionmaking surrounding treatment of depression in pregnancy is complex because the harms of treatments must be balanced against the potential harms to mother and fetus of untreated depression. The objective of this systematic review was to evaluate the benefts and harms of various pharmacological treatment options for depression during pregnancy and the postpartum period compared with each other, with nonpharmacological treatments, and with usual care or no treatment.
This course on the efficacy of pharmacological treatment for women with depression during and after pregnancy is designed for social workers, professional counselors, psychologists, nurses, and substance abuse counselors, who do clinical work. This course is appropriate for beginning, intermediate and advanced level practitioners who wish to develop their understanding of efficacy of pharmacological treatment for women with depression during and after pregnancy. The course material includes a literature review of interventions. It may also be useful for licensed clinicians who require clinical continuing education courses for license renewal.
The course is based on a journal article which includes research. It contains statistical analysis and data that some clinicians enjoy reading and others do not. A major benefit of reading research-based articles for continuing education is they provide practitioners with the latest findings in their field.
Authors: McDonagh, Matthews, Phillipi, Romm, Peterson, Thakurta, Guise.
Learning Objectives: This course will provide the practitioner with detailed information regarding the efficacy of pharmacological treatment for women with depression during and after pregnancy. Specifically, a professional will:
- Describe the maternal benefits of depression treatments during pregnancy
- Recognize the impact on the child when the mother is taking SSRIs during pregnancy
- Explain the links between using anti-depressants during pregnancy and a child having ADHD
Citation: McDonagh, M., Matthews, A., Phillipi, C., Romm, J., Peterson, K., Thakurta, S., & Guise, J. M. (2016). Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period. Evidence Report/Technology Assessment, (216), 1-308.
Visit us online for a full year of unlimited online CEUs.
This Ce-Classes.com course is approved for CE credit by:
- The American Psychological Association (APA) Ce-Classes.com is approved by the American Psychological Association to sponsor continuing education for psychologists. Ce-Classes.com maintains responsibility for this program and its content.
- Association of Social Work Boards (ASWB) Ce-Classes.com, Provider #1142, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Ce-Classes.com maintains responsibility for this course. ASWB Approval Period: 1/5/2020-1/5/2023 Social workers participating in this course will receive 1 Clinical continuing education clock hours.
- The National Board for Certified Counselors (NBCC) Ce-Classes.com has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6320. Programs that do not qualify for NBCC credit are clearly identified. Ce-Classes.com is solely responsible for all aspects of the programs.
- The Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling Provider #852 BAP-Expires 3/31/2023
- The California Board of Behavioral Sciences. The California Board of Behavioral Sciences, BBS, recognizes relevant course work/training that has been approved by nationally recognized certifying bodies, such as APA, to satisfy renewal requirements.
- California Consortium of Addiction Programs and Professionals (CCAPP) Provider Number OS-12-147-0221 Expires 2-2021
- The Texas Board of Social Work Examiners, Continuing Education Provider – 5674 expires 4/30/2021.
- The Texas Board of Professional Counselors, Continuing Education Provider
- Massachusetts Authorization Number: 2196
- Ohio Counselor, Social Worker and Marriage and Family Therapist Board – Provider # RCST031201 Expires 5/31/2021
- New York Social Work Board – Ce-Classes.com is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0120.
- The Florida Board of Nursing (CE Provider #: 50-4896) Expires 10/31/2022 Do not send certificates to the Florida Board of Nursing. You must keep this certificate for 4 years.
- The California Board of Registered Nursing. CEP 15647 Expires 11/30/2022.
This course is Non Interactive .